Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF18 antibody

TNFRSF18 Reactivity: Mouse FACS, IHC (p) Host: Rat Monoclonal 7C13 unconjugated
Catalog No. ABIN360890
  • Target See all TNFRSF18 Antibodies
    TNFRSF18 (Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18))
    Reactivity
    • 56
    • 28
    • 1
    Mouse
    Host
    • 33
    • 25
    • 23
    Rat
    Clonality
    • 48
    • 31
    • 2
    Monoclonal
    Conjugate
    • 44
    • 8
    • 7
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This TNFRSF18 antibody is un-conjugated
    Application
    • 39
    • 33
    • 26
    • 14
    • 14
    • 13
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Specificity
    This antibody recognizes TNFRSF18/GITR.
    Cross-Reactivity (Details)
    Species reactivity (tested):Mouse.
    Purification
    Protein A/G Affinity Chromatography
    Immunogen
    Mouse myeloma fused with spleen cells from a Rat immunized with Mouse T cells.
    Clone
    7C13
    Isotype
    IgG2
    Top Product
    Discover our top product TNFRSF18 Primary Antibody
  • Application Notes
    FACS Analysis: 1/50-1/1000. Immunohistochemistry on Paraffin Sections: 1/50-1/200.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Reconstitution
    Restore with 200 μL sterile PBS (final concentration 500 μg/mL).
    Buffer
    PBS without preservatives or stabilizers
    Preservative
    Without preservative
    Precaution of Use
    Do Not Use Sodium Azide as preservative.
    Handling Advice
    Avoid repeated freezing and thawing. Dilute only prior to immediate use
    Storage
    4 °C/-20 °C
    Storage Comment
    Store vial at 2-8 °C prior to restoration. For extended storage mix with glycerol to 50% and then aliquot contents and freeze at -20 °C or below. Centrifuge product if not completely clear after standing at room temperature. This product is stable for one month at 2-8 °C as an undiluted liquid.
  • Target
    TNFRSF18 (Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18))
    Alternative Name
    TNFRSF18 / GITR (TNFRSF18 Products)
    Synonyms
    GITR antibody, TNFRSF18 antibody, AITR antibody, Gitr antibody, CD357 antibody, GITR-D antibody, TNF receptor superfamily member 18 antibody, tumor necrosis factor receptor superfamily, member 18 antibody, TNFRSF18 antibody, Tnfrsf18 antibody
    Background
    TNFRSF18 or GITR (glucocorticoid-induced TNF receptor family-regulated gene) is a 25 kD TNF receptor superfamily member (also known as AITR and TNFRSF18) originally identified in the mouse by comparing untreated and dexamethasone-treated murine T cell hybridoma cells. Human GITR was subsequently identified by searching an expressed sequence tag database. GITR is expressed on activated lymphocytes and is upregulated by T cell receptor engagement. The cytoplasmic domain of GITR is homologous to CD40, 4-1BB and CD27 and has been shown to interact with TRAF 1-3, but not TRAF 5 or 6. GITR signaling has been shown to regulate T cell proliferation and TCR-mediated apoptosis, and to break immunological self-tolerance. GITR appears to be highly expressed on CD4+CD25+ T regulatory cells and has been shown to induce NF-kB activation through TRAF2/NIK signaling. GITR has been proposed to be involved in the development of regulatory T cells and to regulate the activity of Th1 subsets. GITR binds GITRL, a TNF superfamily ligand expressed on endothelial cells, dendritic cells, macrophages, and B cells.Synonyms: AITR, Activation-inducible TNFR family receptor, Glucocorticoid-induced TNFR-related protein, Tumor necrosis factor receptor superfamily member 18
    Gene ID
    8784
    NCBI Accession
    NP_004186
    UniProt
    Q9Y5U5
    Pathways
    Cancer Immune Checkpoints
You are here:
Support